MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 584521 | Name: KR 60436

Description:

WARNING: This product is for research use only, not for human or veterinary use.

KR 60436 is an inhibitor of potassium hydrogen ATPase.

Chemical Structure

KR 60436
KR 60436
CAS#220853-65-6

Theoretical Analysis

MedKoo Cat#: 584521

Name: KR 60436

CAS#: 220853-65-6

Chemical Formula: C22H22F3N3O3

Exact Mass: 433.1613

Molecular Weight: 433.43

Elemental Analysis: C, 60.97; H, 5.12; F, 13.15; N, 9.69; O, 11.07

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
KR 60436; KR60436; KR-60436
IUPAC/Chemical Name
1-(2-Methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline
InChi Key
ZFDXQUVDLKGYIL-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H22F3N3O3/c1-13-12-14(30-2)6-7-17(13)28-10-8-16-20(28)15-4-3-5-18(31-22(23,24)25)19(15)27-21(16)26-9-11-29/h3-7,12,29H,8-11H2,1-2H3,(H,26,27)
SMILES Code
FC(OC1=C2N=C(NCCO)C3=C(N(C4=CC=C(OC)C=C4C)CC3)C2=CC=C1)(F)F
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 433.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lee HM, Lee HY, Choi JK, Lee HS. High performance liquid chromatographic analysis of a new proton pump inhibitor KR60436 and its active metabolite O-demethyl-KR60436 in rat plasma samples using column-switching. Arch Pharm Res. 2001 Jun;24(3):207-10. PubMed PMID: 11440078. 2: Choi SJ, Ji HY, Baek SK, Lee HY, Choi JK, Cheon HG, Lee DH, Lim H, Lee HS. LC-MS/MS identification of in vitro metabolites of a new H+/K+ ATPase inhibitor, KR-60436 produced by rat and human liver microsomes. J Pharm Biomed Anal. 2002 Jun 1;28(5):897-902. PubMed PMID: 12039631. 3: Yu SY, Bae SK, Kim EJ, Kim YG, Kim SO, Lee DH, Lim H, Lee MG. Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect. J Pharm Sci. 2003 Aug;92(8):1592-603. PubMed PMID: 12884246. 4: Ji HY, Lee HW, Kim HH, Choi JK, Lee HS. Characterization of human liver cytochrome P450 enzymes involved in the metabolism of a new H+/K+-ATPase inhibitor KR-60436. Toxicol Lett. 2005 Jan 15;155(1):103-14. PubMed PMID: 15585365.